Neoantigen Off-the-shelf Vaccine

Type: vaccine

Status: Investigational

Developer: Multiple (Gritstone/BioNTech)

Breakthrough Summary

No summary available.

Mechanism of Action

Pre-made vaccine targeting common colorectal cancer neoantigens

Year: 2025-2026